Evidence map›Paper›PMID 25419508›Full record

ArticleCurrent treatment options in allergy2014

The Potential of Anti-IgE in Food Allergy Therapy.

Monali Manohar, Kari C Nadeau

Abstract read
In one paragraph

Article in Current treatment options in allergy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. THE JEREMIAH METZGER LECTURE NOVEL THERAPEUTIC STRATEGIES OF ALLERGIC AND IMMUNOLOGIC DISORDERS.Transactions of the American Clinical and Climatological Association · 2018
    Review
  6. Article
  7. Improving the safety of oral immunotherapy for food allergy.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2016
    Review
  8. Off-Label Uses of Omalizumab.Clinical reviews in allergy & immunology · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Monali ManoharDepartment of Pediatrics, Division of Immunology and Allergy Stanford University 300 Pasteur Drive, Stanford, CA 94305.
Kari C NadeauDepartment of Pediatrics, Division of Immunology and Allergy Stanford University 300 Pasteur Drive, Stanford, CA 94305.

Funding

Tracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI CHINTHRAJAH, R. SHARON · 2013 to 2025
$17.3M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
Development of Improved Diagnostic Allergy TestR21AI095838 · NIAID · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2011 to 2012
$435k
NIAID NIH HHS R21 AI095838NIAID NIH HHS U01 AI147462NIAID NIH HHS U19 AI104209
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anaphylaxisdesensitizationFood allergyIgEomalizumaboral food challengeoral immunotherapytolerance

Identifiers

PMID25419508
PMCPMC4235522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.